PVCT — Provectus Biopharmaceuticals Inc · rev $336.1K

Provectus Biopharmaceuticals Inc (PVCT) is a biotechnology company listed on OTCQB.

Latest reported PVCT revenue for 2025-09-30 was $336.1K. Net income was -$1.3M. PVCT currently screens at market cap $25.9M.

Use this PVCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PVCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PVCT SEC filings page. Lician reads the product cache first so this HTML stays unique to Provectus Biopharmaceuticals Inc even when a live quote feed is slow.

Provectus Biopharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full PVCT income, balance, and cash tables.

  • Revenue$336.1K
  • Net Income-$5.4M
  • Total Assets$697.5K
  • Total Debt$0
  • Free Cash Flow$0

PVCT recent filings